| 摘要 |
FIELD: medicine.SUBSTANCE: invention relates to medicine, namely to endocrinology, and deals with treatment of diabetes mellitus. For this purpose pharmaceutical composition, containing activated-potentiated form of antibodies to insulin receptor and activated-potentiated form of antibodies to endothelial NO-synthase, is additionally introduced at the background of treatment of diabetes with insulin and/or hypoglycaemic medications.EFFECT: method provides increase of treatment efficiency with reduction of dose of insulin and hypoglycaemic medications, which, in its turn, results in reduction of side effects.4 cl, 5 ex |
